Publications Office of the EU
Germany-Magdeburg: Pharmaceutical products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Germany-Magdeburg: Pharmaceutical products

  • Awarded
    31/08/2023
  • Today
    17/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Sachsen - Anhalt
Place of performance
NUTS code: DEE Sachsen-Anhalt
Location of buyer
NUTS code: DEE03 Magdeburg, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
215,000.00
Total final contract value (excluding VAT)
215,000.00 EUR
Tender reference number
AOK SAN 2023- 0041
Description

AOK Sachsen-Anhalt concluded a contract with the manufacturer of the medicinal product NovoEight (B02BD02) for the treatment of haemophilia on 1 September 2023 in accordance with § 130a(8) SGB V in conjunction with § 130c(1) SGB V.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Lowest price
Estimated value
215,000.00
Final contracted value
215,000.00 EUR
Award of contract
Official name: Novo Nordisk Pharma GmbH
Postal address: Brucknerstrasse 1
Town: Mainz
Postal code: 55127
Country: DEU
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.